Refer a Patient Request an Appointment
Adel M. Malek, MD, PhDNeurovascular Surgery · Boston

2021 · Devices & clinical

Age and Acute Ischemic Stroke Outcome in North American Patients With COVID-19

Dmytriw AA, Dibas M, Schirmer CM, Settecase F, Heran MKS, Efendizade A, Kühn AL, Puri AS, Ospel J, Menon B, Sivakumar S, Mowla A, Vela-Duarte D, Linfante I, Dabus G, Regenhardt RW, Patel AB, Leslie-Mazwi T, D'Amato S, Rosenthal J, Zha A, Talukder N, Sheth S, Cooke D, Leung LY, Malek A, Voetsch B, Sehgal S, Wakhloo AK, Wu H, Cohen J, Turkel-Parella D, Xavier A, Tiwari A, North American Neurovascular COVID‐19 (NAN‐C) Consortium.

J Am Heart Assoc 10(14):e021046, 2021.

PMID 34219466 · DOI 10.1161/JAHA.121.021046 · PMCID PMC8483479

In plain language

Strokes caused by a blocked artery drew attention early in the pandemic because they appeared to strike people with COVID-19 at any age, including the young. This study asked how age affected recovery and survival.

Share of patients with COVID-19 and stroke who died, by age group.
Share of patients with COVID-19 and stroke who died, by age group.Chart drawn for this site from data in Dmytriw AA et al. J Am Heart Assoc, 2021.

A database from stroke centers in Canada and the United States was reviewed for 126 patients who had this kind of stroke and tested positive for SARS-CoV-2 between March 14 and September 30, 2020. The median age was 63 years, with a range of 27 to 94. Deaths were less frequent in younger patients: 21.9 percent for those aged 55 and under, 45.0 percent for ages 56 to 70, and 48.8 percent for those over 70. Each additional year of age was linked to a lower chance of good recovery.

Poor outcomes still tracked closely with older age.

A plain-language summary for patients and families. It is not medical advice, and individual results vary.

Abstract

Background Acute ischemic stroke (AIS) in the context of COVID-19 has received considerable attention for its propensity to affect patients of all ages. We aimed to evaluate the effect of age on functional outcome and mortality following an acute ischemic event. Methods and Results A prospectively maintained database from comprehensive stroke centers in Canada and the United States was analyzed for patients with AIS from March 14 to September 30, 2020 who tested positive for SARS-CoV-2. The primary outcome was Modified Rankin Scale score at discharge, and the secondary outcome was mortality. Baseline characteristics, laboratory values, imaging, and thrombectomy workflow process times were assessed. Among all 126 patients with COVID-19 who were diagnosed with AIS, the median age was 63 years (range, 27-94). There were 35 (27.8%) patients with AIS in the aged ≤55 years group, 47 (37.3%) in the aged 56 to 70 group, and 44 (34.9%) in the aged >70 group. Intravenous tissue plasminogen activator and thrombectomy rates were comparable across these groups, (P=0.331 and 0.212, respectively). There was a significantly lower rate of mortality between each group favoring younger age (21.9% versus 45.0% versus 48.8%, P=0.047). After multivariable adjustment for possible confounders, a 1-year increase in age was significantly associated with fewer instances of a favorable outcome of Modified Rankin Scale 0 to 2 (odds ratio [OR], 0.95; 95 CI%, 0.90-0.99; P=0.048) and higher mortality (OR, 1.06; 95 CI%, 1.02-1.10; P=0.007). Conclusions AIS in the context of COVID-19 affects young patients at much greater rates than pre-pandemic controls. Nevertheless, instances of poor functional outcome and mortality are closely tied to increasing age.

Abstract as indexed in PubMed (PMID 34219466). Copyright the publisher.

Cite this paper

Dmytriw AA, Dibas M, Schirmer CM, Settecase F, Heran MKS, Efendizade A, Kühn AL, Puri AS, Ospel J, Menon B, Sivakumar S, Mowla A, Vela-Duarte D, Linfante I, Dabus G, Regenhardt RW, Patel AB, Leslie-Mazwi T, D'Amato S, Rosenthal J, Zha A, Talukder N, Sheth S, Cooke D, Leung LY, Malek A, Voetsch B, Sehgal S, Wakhloo AK, Wu H, Cohen J, Turkel-Parella D, Xavier A, Tiwari A, North American Neurovascular COVID‐19 (NAN‐C) Consortium. Age and Acute Ischemic Stroke Outcome in North American Patients With COVID-19. J Am Heart Assoc 10(14):e021046. 2021. doi:10.1161/JAHA.121.021046 PMID: 34219466.